Search results: Sage Journals

Open accessResearch articleFirst published 2024

Efficacy of carboplatin–etoposide rechallenge after first-line chemo-immunotherapy in ES-SCLC: an international multicentric analysis

Igor Gomez-Randulfe, Sofía Silva Díaz, Carles Escriu [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published January, 2025

Efficacy and Safety of Anlotinib and PD-1/L1 Inhibitors as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer Patients who Have Achieved Stable-Disease After First-Line Treatment with Chemotherapy and Immunotherapy: A Retrospective Study

Yi Peng, De Wu, Jing Tang [...]

Cancer Control

Open accessResearch articleFirst published 2026

Adebrelimab-based regimens as first-line treatment for ES-SCLC in specific populations: a real-world study in Chinese patients

Liyang Jiang, Junxu Wen, Shuangbing Xu [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2021

Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses

Valerio Gristina, Antonio Galvano, Luisa Castellana [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2025

Impact of delayed addition of PD-1/PD-L1 inhibitors to chemotherapy on outcomes in patients with extensive-stage small cell lung cancer

Shuangqing Lu, Chao Wang, Xiaoyang Zhai [...]

Therapeutic Advances in Medical Oncology

Open accessReview articleFirst published 2023

The role of thoracic consolidative radiotherapy in the setting of immunotherapy in extensive stage small cell lung cancer

Saurav Verma, Sympascho Young, Alexander V. Louie [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2025

Real-world evidence for immunotherapy in the first-line or subsequent-line setting in extensive-stage small-cell lung cancer

Ruizi Ren, Ying Wang, Qunhui Wang [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2022

Effectiveness and Safety of Anlotinib Monotherapy for Patients with Extensive-stage Small-Cell Lung Cancer Who Progressed to Chemotherapy: A Real-world Exploratory Study

Yonghui Li, Zhenqing Sun, Wei Sun [...]

Clinical Medicine Insights: Oncology

Open accessReview articleFirst published 2025

Current and future perspectives in extensive-stage small-cell lung cancer

Jeong Uk Lim, Woo Kyung Ryu, Nuri Park [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published May, 2025

Which Types of Patients With Extensive-Stage Small Cell Lung Cancer Benefit From Radiotherapy? A Retrospective Study Integrating Machine Learning With the SEER Database and a Chinese Cohort

Haojun Wang, Huiru Zhang, Yan Yao [...]

Cancer Control

Open accessResearch articleFirst published 2024

Efficacy of carboplatin–etoposide rechallenge after first-line chemo-immunotherapy in ES-SCLC: an international multicentric analysis

Igor Gomez-Randulfe, Sofía Silva Díaz, Carles Escriu [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published January, 2025

Efficacy and Safety of Anlotinib and PD-1/L1 Inhibitors as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer Patients who Have Achieved Stable-Disease After First-Line Treatment with Chemotherapy and Immunotherapy: A Retrospective Study

Yi Peng, De Wu, Jing Tang [...]

Cancer Control

Open accessResearch articleFirst published 2026

Adebrelimab-based regimens as first-line treatment for ES-SCLC in specific populations: a real-world study in Chinese patients

Liyang Jiang, Junxu Wen, Shuangbing Xu [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2021

Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses

Valerio Gristina, Antonio Galvano, Luisa Castellana [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2025

Impact of delayed addition of PD-1/PD-L1 inhibitors to chemotherapy on outcomes in patients with extensive-stage small cell lung cancer

Shuangqing Lu, Chao Wang, Xiaoyang Zhai [...]

Therapeutic Advances in Medical Oncology

Open accessReview articleFirst published 2023

The role of thoracic consolidative radiotherapy in the setting of immunotherapy in extensive stage small cell lung cancer

Saurav Verma, Sympascho Young, Alexander V. Louie [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2025

Real-world evidence for immunotherapy in the first-line or subsequent-line setting in extensive-stage small-cell lung cancer

Ruizi Ren, Ying Wang, Qunhui Wang [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2022

Effectiveness and Safety of Anlotinib Monotherapy for Patients with Extensive-stage Small-Cell Lung Cancer Who Progressed to Chemotherapy: A Real-world Exploratory Study

Yonghui Li, Zhenqing Sun, Wei Sun [...]

Clinical Medicine Insights: Oncology

Open accessReview articleFirst published 2025

Current and future perspectives in extensive-stage small-cell lung cancer

Jeong Uk Lim, Woo Kyung Ryu, Nuri Park [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published May, 2025

Which Types of Patients With Extensive-Stage Small Cell Lung Cancer Benefit From Radiotherapy? A Retrospective Study Integrating Machine Learning With the SEER Database and a Chinese Cohort

Haojun Wang, Huiru Zhang, Yan Yao [...]

Cancer Control